Trial Profile
Combination of Gonadotropin-releasing Hormone Agonist and Human Chorionic Gonadotropin Triggered by Normal Responder in GnRH-antagonist Cycles
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Choriogonadotropin alfa (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- 22 Aug 2016 New trial record